DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nine-amino-acid neuropeptide (nonapeptide) originally isolated during research into sleep-associated brain activity.

Its amino-acid sequence is:

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

DSIP has attracted research interest for its potential involvement in sleep regulation, circadian rhythms, neurological signalling, stress responses and neuroendocrine function.

Key Research Areas

Sleep & Delta-Wave Research
DSIP was originally identified because of its association with slow-wave (delta) EEG activity. Early experimental studies demonstrated increased delta-wave activity following administration, leading to the name Delta Sleep-Inducing Peptide.

Insomnia & Sleep Quality Research
DSIP has undergone small human clinical studies involving chronic insomnia. A double-blind study of 16 people found higher sleep efficiency and shorter sleep latency compared with placebo, although the researchers concluded that the effects were weak and that short-term DSIP was unlikely to provide major therapeutic benefit.

Other older controlled studies reported improvements in sleep parameters, illustrating that the available human evidence is mixed rather than conclusive.

Circadian Rhythm Research
Research has investigated DSIP’s influence beyond sleep itself, including potential effects on circadian rhythms, locomotor activity and neurochemical signalling.

Stress & Neuroendocrine Research
DSIP has also been investigated in relation to the body’s stress-response systems. A randomized double-blind crossover study in healthy men reported a reduction in ACTH-like immunoreactivity following intravenous DSIP, while cortisol levels were not significantly affected.

Neurological & Neurotransmitter Research
Experimental research has explored DSIP’s potential influence on:

• Neurotransmitter activity
• EEG patterns
• Circadian signalling
• Stress responses
• Hormonal regulation
• Sleep-wake cycles
• Behavioural and neurological function

These observations have led researchers to consider DSIP a potentially multifunctional regulatory peptide, rather than simply a conventional sedative.